Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors.

about

Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS.

P2860

Q41002630-C3AEEEF8-D3C3-40FA-9027-BFF3890E8C50

P2860

Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors.

Item

http://www.wikidata.org/entity/Q38838740

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inhibition of sodium-independe ...... by tyrosine kinase inhibitors.

@en

type

Item

label

Inhibition of sodium-independe ...... by tyrosine kinase inhibitors.

@en

prefLabel

Inhibition of sodium-independe ...... by tyrosine kinase inhibitors.

@en

P1476

Inhibition of sodium-independe ...... by tyrosine kinase inhibitors.

@en

P2093

Carol E Cass

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

Michelle Kuzma

http://www.w3.org/2001/XMLSchema#string

Vijaya L Damaraju

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma.

Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial.

A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance

Population pharmacokinetic analysis of sorafenib in patients with solid tumours.

Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.

Pharmacokinetic evaluation of capecitabine in breast cancer.

The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29.

Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?

Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers.

P2888

s00280-015-2859-8

P304

1093-1098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-015-2859-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281517700

http://www.w3.org/2001/XMLSchema#string

P6179

1023218972

http://www.w3.org/2001/XMLSchema#string

P698

26330332

http://www.w3.org/2001/XMLSchema#string

Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors.

about

P2860

P2860

Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698